Clinique de Chirurgie Digestive et Endocrinienne, Institut des Maladies de l'Appareil Digestif, Centre Hospitalier Universitaire (CHU) Nantes – Hôtel Dieu, Nantes, France.
Br J Surg. 2013 Sep;100(10):1312-7. doi: 10.1002/bjs.9210.
The treatment of papillary thyroid carcinomas larger than 1 cm usually consists of total thyroidectomy and central lymph node dissection (LND). In patients with the follicular variant of papillary thyroid carcinoma (FVPTC), preoperative cytology and intraoperative frozen-section analysis cannot always establish the diagnosis. The aim of this study was to evaluate predictive factors for lymph node metastasis in patients with FVPTC and to identify patients who might benefit from LND.
The study included patients with FVPTC treated by total thyroidectomy and LND between 2000 and 2010 in four departments. When fewer than six non-involved lymph nodes were removed, the patient was excluded from the analysis.
Some 199 patients were included. The median tumour size was 17 (range 1-85) mm, and tumours were classified as T1a in 28 patients, T1b in 40, T2 in 53, and T3 in 78. Eighty-one patients (40·7 per cent) had lymph node metastasis (51 classified as N1a and 30 as N1b). Four risk factors were predictive of lymph node metastasis in the multivariable analysis: multifocality (odds ratio (OR) 2·36, 95 per cent confidence interval 1·15 to 4·86), angiolymphatic invasion (OR 3·67, 1·01 to 13·36), absence of tumour capsule (OR 3·00, 1·47 to 6·14) and tumour involvement of perithyroid tissue (OR 3·89, 1·85 to 8·18). The rate of lymph node metastasis varied between 14 and 94 per cent depending on the presence of risk factors.
The rate of lymph node metastasis in patients with FVPTC varies widely according to the presence or absence of predictive risk factors.
直径大于 1 厘米的甲状腺乳头状癌的治疗通常包括甲状腺全切除术和中央淋巴结清扫术(LND)。在甲状腺滤泡状癌(FVPTC)患者中,术前细胞学和术中冷冻切片分析并不总能确定诊断。本研究旨在评估 FVPTC 患者淋巴结转移的预测因素,并确定可能受益于 LND 的患者。
该研究纳入了 2000 年至 2010 年在四个科室接受甲状腺全切除术和 LND 治疗的 FVPTC 患者。当切除的非受累淋巴结少于 6 个时,患者被排除在分析之外。
共有 199 例患者纳入分析。肿瘤的中位大小为 17(范围 1-85)mm,28 例患者的肿瘤分类为 T1a,40 例为 T1b,53 例为 T2,78 例为 T3。81 例(40.7%)患者有淋巴结转移(51 例为 N1a,30 例为 N1b)。多变量分析显示,有 4 个危险因素可预测淋巴结转移:多灶性(优势比(OR)2.36,95%置信区间 1.15-4.86)、血管淋巴管侵犯(OR 3.67,1.01-13.36)、无肿瘤包膜(OR 3.00,1.47-6.14)和肿瘤累及甲状腺周围组织(OR 3.89,1.85-8.18)。根据危险因素的存在与否,淋巴结转移率在 14%至 94%之间变化。
FVPTC 患者的淋巴结转移率根据预测性危险因素的存在与否而有很大差异。